
Chronic lymphocytic leukemia - Symptoms and causes - Mayo …
Oct 24, 2025 · Chronic lymphocytic leukemia (CLL) is a type of leukemia. Leukemia is cancer that affects the blood and bone marrow. Bone marrow is the spongy tissue inside bones where …
What Is Chronic Lymphocytic Leukemia (CLL)? - American …
Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia in adults. It's a type of cancer that starts in early forms of certain white blood cells (called lymphocytes) in the …
Chronic lymphocytic leukemia - Wikipedia
This subtype, termed chronic lymphocytic leukemia-type MBL (CLL-type MBL) is an asymptomatic, indolent, and chronic disorder in which people exhibit a mild increase in the …
Chronic Lymphocytic Leukemia Treatment - NCI
Oct 15, 2024 · Chronic lymphocytic leukemia (CLL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). CLL is a cancer of the blood and …
Chronic Lymphocytic Leukemia: Causes, Symptoms, Treatment
Learn the causes, symptoms, and treatment of chronic lymphocytic leukemia, a blood cancer.
Chronic Lymphocytic Leukemia | CLL | MedlinePlus
Nov 27, 2023 · Chronic Lymphocytic Leukemia or CLL is cancer of the white blood cells, where abnormal cells are made. This makes it hard for the blood to do its work.
What is chronic lymphocytic leukemia (CLL)? - Medical News …
Jun 10, 2025 · Chronic lymphocytic leukemia is a cancer that affects bone marrow, causing an overproduction of lymphocytes, a type of white blood cell. CLL is one of the most common …
CLL Society, the Leading Authority for CLL and SLL Patients
Everyone diagnosed with chronic lymphocytic leukemia (CLL) deserves quality care and support for their cancer. CLL Society is here to provide education and support to ensure no one goes …
Chronic Lymphocytic Leukemia (CLL) - Memorial Sloan Kettering …
Chronic lymphocytic leukemia (CLL) is the most common chronic leukemia in adults. Therapies for CLL are improving and changing rapidly. Learn about treatments for CLL.
First-line treatment for CLL in the era of targeted therapy
6 days ago · Abstract In the decade since FDA approval of the first-generation Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib, the treatment landscape for chronic lymphocytic leukemia …